Dest VM. Neurologic, ocular, and dermatologic toxicities. In Holmes Gobel B, Triest-Robinson S, Vogel WH, eds. Advanced Oncology Nursing Certification and Review Resource Manual. 2nd ed. Pittsburgh, PA. Oncology Nursing Society; 2016:611-614.
 Katz A.  Scalp cooling.  Clin J Oncology Nurs. 2017; 21(4):413-415.
 Komen MMC, van den Hurk CJG, Nortier JWR, van der Ploeg T, Smorenburg CH, van der Hoeven JJM. Patient-oriented outcome assessment and
 objective evaluation of chemotherapy-induced alopecia. Eur J Oncol Nurs. 2018; 33:49-55. 
 Lacouture ME. Management of Dermatologic Toxicities.  J National Comprehensive Cancer Network. 2015;13(5.5):686-689.
 Maeng HM, Berger AM.  Hair loss and other hair changes.  In DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer:
 Principles and Practice of Oncology. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2019: 2129-2133.
 Nail LM, Lee-Lin F. Alopecia. In Brown CG, ed. A Guide to Oncology Symptom Management. 2nd ed. Pittsburgh, PA. Oncology Nursing Society;
 2015:21-33.
 Pappas-Taffer L, Kachiu Lee H, Higgins W, Robinson-Bostom L, McDonald DJ. Dermatologic toxicities of anticancer therapies. In Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia: Elsevier, 2014:648-675.
 Roe H. Chemotherapy-induced alopecia: Advice and support for hair loss. Br J Nurs. 2011; 20(10):S4-11.
 Suchonwanit P, McMichael AJ. Alopecia in association with malignancy: A review. Am J Clin Dermatol. 2018; 19(6):853-865.